NCT03688711View on ClinicalTrials.gov

Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

March 11, 2019

Study Completion Date

March 11, 2019

Conditions
HypoglycemiaDiabetes Mellitus, Type 1
Interventions
DRUG

Dasiglucagon

Glucagon analogue

DRUG

Placebo

Placebo for dasiglucagon

Trial Locations (3)

91911

ProSciento, Inc., Chula Vista

92025

AMCR Institute, Escondido

98057

Rainier Clinical Research, Inc., Renton

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY

NCT03688711 - Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM | Biotech Hunter | Biotech Hunter